Causes of death for HIV-Ly and Control-Ly cohorts
| . | HIV-Ly cohort . | Control-Ly cohort . | ||
|---|---|---|---|---|
| n . | % . | n . | % . | |
| Death events | 19 | 36 | 14 | 26.5 |
| Relapse/progression | 13 | 69 | 13 | 93 |
| Secondary malignancy | 1 | 5 | 0 | 0 |
| Infectious-related (< 4 mo after ASCT) | 3 | 16 | 0 | 0 |
| Non–ASCT-related late infection complication | 1 | 5 | 0 | 0 |
| Other | 0 | 0 | 1 | 7 |
| Unknown | 1 | 5 | 0 | 0 |
| . | HIV-Ly cohort . | Control-Ly cohort . | ||
|---|---|---|---|---|
| n . | % . | n . | % . | |
| Death events | 19 | 36 | 14 | 26.5 |
| Relapse/progression | 13 | 69 | 13 | 93 |
| Secondary malignancy | 1 | 5 | 0 | 0 |
| Infectious-related (< 4 mo after ASCT) | 3 | 16 | 0 | 0 |
| Non–ASCT-related late infection complication | 1 | 5 | 0 | 0 |
| Other | 0 | 0 | 1 | 7 |
| Unknown | 1 | 5 | 0 | 0 |